Gecse, Krisztina; Lovász, Barbara Dorottya; Farkas, Klaudia; Banai J; Bene L; Gasztonyi, Beáta; Golovics, Petra Anna; Kristóf T; Lakatos, László; Csontos, Ágnes Anna; Juhász, Márk; Nagy, Ferenc; Palatka, Károly; Papp, Mária; Patai, Árpád; Lakner L; Salamon A; Szamosi T; Szepes, Zoltán; Tóth GT; Vincze, Áron; Szalay, Balázs; Molnár, Tamás; Lakatos, Péter László
(2016)
Background and Aims:
Biosimilar infliximab CT-P13 is approved for all indications of the originator product in Europe. Prospective data on its efficacy, safety, and immunogenicity in inflammatory bowel diseases are ...